Cancer in the UK -  Digital Data Toolkit

The data in the toolkit is drawn from the Institute for Health Economics Comparator Report on Patients Access to Cancer Medicines Revisited - a UK Perspective.

Collaboration vital to restoring and improving NHS cancer services

Reversing the impact of the coronavirus pandemic and improving long-term cancer outcomes is only possible if the entire UK cancer community comes together, says a new report.

Who we are

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines and vaccines. We represent companies of all sizes who invest in discovering the medicines of the future.

Our members supply cutting edge treatments that improve and save the lives of millions of...

Why vaccines matter

Vaccines developed by the pharmaceutical industry save lives, prevent diseases, benefit our economy and support the NHS.

How are vaccines researched and developed?

The UK has a longstanding reputation for vaccine development.

ABPI response to EU data adequacy decision

The European Commission has issued a positive preliminary data adequacy decision for the UK which will allow data to continue to flow freely from the EU to the UK.

ABPI response to Life Science Competitiveness Indicators

The government has published new data on the life science sector in the UK and other countries.

What impact will coronavirus have on the medicines supply chain?

Our members are working 24/7 to get medicines to patients during the coronavirus pandemic. 

What Government guidance and advice is available?

Bringing together the most up-to-date information from the UK Government.

What is the life sciences sector doing to help increase COVID-19 testing?

The Government has confirmed that COVID-19 testing capacity will increase. 

How are life sciences companies helping the NHS on the ground?

As part of the health community, the life sciences sector in the UK wants to play as big a role as possible in tackling COVD-19.